Titan Pharmaceuticals
TTNP
#10414
Rank
HK$47.73 M
Marketcap
HK$35.89
Share price
-3.76%
Change (1 day)
23.64%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.17. In 2023 the company made an earnings per share (EPS) of -HK$57.68 an increase over its 2022 EPS that were of -HK$118.25.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$57.68-51.22%
2022-HK$118.25-15.61%
2021-HK$140.12-81.37%
2020-HK$751.99-77.52%
2019-HK$3,346-56.32%
2018-HK$7,660-59.51%
2017-HK$18,921-371.81%
2016HK$6,961-144.35%
2015-HK$15,694300%
2014-HK$3,923-121.54%
2013HK$18,216-151.38%
2012-HK$35,451-11.54%
2011-HK$40,075188.89%
2010-HK$13,872-10%
2009-HK$15,414
2007-HK$63,196-2.38%
2006-HK$64,737-39.13%
2005-HK$106,354-16.87%
2004-HK$127,933-22.43%
2003-HK$164,9264.9%
2002-HK$157,21961.9%
2001-HK$97,106-13.7%
2000-HK$112,52065.01%
1999-HK$68,191-35.87%
1998-HK$106,336-1824.71%
1997HK$6,165-102.4%
1996-HK$257,408

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-HK$11.05-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.87-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.31-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.27-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.29-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
HK$0.23-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA